Milestone Pharmaceuticals Inc. announced the appointment of Francis Plat, MD, FAHA, as Chief Medical Officer of the company. Dr. Plat is a board-certified cardiologist with extensive experience in cardiovascular drug development. Most recently, Dr. Plat was Vice President and Therapeutic Area Head, Atherosclerosis and Cardiovascular at Merck Research Laboratories.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.46 USD | -1.35% | -2.67% | -12.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.57% | 96.59M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- MIST Stock
- News Milestone Pharmaceuticals Inc.
- Milestone Pharmaceuticals Inc. Appoints Francis Plat as Chief Medical Officer